Kolon Biotech, Inc. announced a private placement of 67,000 common shares at an issue price of KRW 15,000 for proceeds of KRW 1,005,000,000 on March 28, 2023. The transaction has been approved by the board of directors. The transaction will include participation from returning investor Kolon Life Science Inc. The shares will be issued pursuant to shareholder allocation method.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,100 KRW | -0.23% | +0.23% | -14.01% |
1st Jan change | Capi. | |
---|---|---|
-14.01% | 186M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- A102940 Stock
- News Kolon Life Science Inc.
- Kolon Biotech, Inc. announced that it expects to receive KRW 1.005 billion in funding from Kolon Life Science Inc.